These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29485042)

  • 1. Association Between Treatment at High-Volume Facilities and Improved Overall Survival in Soft Tissue Sarcomas.
    Venigalla S; Nead KT; Sebro R; Guttmann DM; Sharma S; Simone CB; Levin WP; Wilson RJ; Weber KL; Shabason JE
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):1004-1015. PubMed ID: 29485042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Treatment at a High-volume Center Associated with an Improved Survival for Primary Malignant Bone Tumors?
    Malik AT; Alexander JH; Khan SN; Scharschmidt TJ
    Clin Orthop Relat Res; 2020 Mar; 478(3):631-642. PubMed ID: 31714413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma.
    Keung EZ; Chiang YJ; Cormier JN; Torres KE; Hunt KK; Feig BW; Roland CL
    Cancer; 2018 Dec; 124(23):4495-4503. PubMed ID: 30317543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soft Tissue Sarcoma of the Extremities: What Is the Value of Treating at High-volume Centers?
    Lazarides AL; Kerr DL; Nussbaum DP; Kreulen RT; Somarelli JA; Blazer DG; Brigman BE; Eward WC
    Clin Orthop Relat Res; 2019 Apr; 477(4):718-727. PubMed ID: 30485258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming a travel burden to high-volume centers for treatment of retroperitoneal sarcomas is associated with improved survival.
    Schmitz R; Adam MA; Blazer DG
    World J Surg Oncol; 2019 Nov; 17(1):180. PubMed ID: 31684956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in practice patterns and outcomes: A decade of sarcoma care in the United States.
    Song Y; Ecker BL; Tang R; Maggino L; Roses RE; DeMatteo RP; Fraker DL; Karakousis GC
    Surg Oncol; 2019 Jun; 29():168-177. PubMed ID: 31196484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is There an Association Between Insurance Status and Survival and Treatment of Primary Bone and Extremity Soft-tissue Sarcomas? A SEER Database Study.
    Smartt AA; Jang ES; Tyler WK
    Clin Orthop Relat Res; 2020 Mar; 478(3):527-536. PubMed ID: 31390340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved survival for extremity soft tissue sarcoma treated in high-volume facilities.
    Abarca T; Gao Y; Monga V; Tanas MR; Milhem MM; Miller BJ
    J Surg Oncol; 2018 Jun; 117(7):1479-1486. PubMed ID: 29633281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Treatment at a High-Volume Facility and Improved Survival for Radiation-Treated Men With High-Risk Prostate Cancer.
    Chen YW; Mahal BA; Muralidhar V; Nezolosky M; Beard CJ; Den RB; Feng FY; Hoffman KE; Martin NE; Orio PF; Nguyen PL
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):683-90. PubMed ID: 26972640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Socio-economic factors do not affect overall survival in soft tissue sarcoma when patients treated at a single high-volume center.
    Eastman BM; Hippe DS; Wootton LS; Nyflot MJ; Thompson MJ; Pollack SM; Kim E; Spraker MB
    BMC Cancer; 2021 May; 21(1):620. PubMed ID: 34039294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of treating facilities' type and volume in patients with major salivary gland cancer.
    Bollig CA; Zitsch RP
    Laryngoscope; 2019 Oct; 129(10):2321-2327. PubMed ID: 30698823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased survival of non low-grade and deep-seated soft tissue sarcoma after surgical management in high-volume hospitals: a nationwide study from the Netherlands.
    Vos M; Blaauwgeers HGT; Ho VKY; van Houdt WJ; van der Hage JA; Been LB; Bonenkamp JJ; Bemelmans MHA; van Dalen T; Haas RL; Grünhagen DJ; Verhoef C;
    Eur J Cancer; 2019 Mar; 110():98-106. PubMed ID: 30776758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in receipt of therapy and survival with provider volume for medical oncology in non-curative esophago-gastric cancer: a population-based analysis.
    Hallet J; Davis LE; Mahar AL; Liu Y; Zuk V; Gupta V; Earle CC; Coburn NG
    Gastric Cancer; 2020 Mar; 23(2):300-309. PubMed ID: 31628561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Academic Facility Type and Case Volume on Survival in Patients Undergoing Curative Radiation Therapy for Muscle-Invasive Bladder Cancer.
    Bajaj A; Martin B; Bhasin R; Hentz C; Block AM; Harkenrider MM; Solanki AA
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):851-857. PubMed ID: 29485062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of health insurance status with presentation, treatment and outcomes in soft tissue sarcoma.
    Jain V; Venigalla S; Sebro RA; Karakousis GC; Wilson RJ; Weber KL; Shabason JE
    Cancer Med; 2019 Oct; 8(14):6295-6304. PubMed ID: 31483578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between facility case volume and overall survival in patients with metastatic renal cell carcinoma in the targeted therapy era.
    Chen YW; Ornstein MC; Wood LS; Allman KD; Martin A; Beach J; Gilligan T; Garcia JA; Rini BI
    Urol Oncol; 2018 Oct; 36(10):470.e19-470.e29. PubMed ID: 30131292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Not Available].
    Dykes KC; Chou J; Taylor AO; Shu AC; Mudra SE; Ma X; Ahn J; Lai CE
    Cancer Rep (Hoboken); 2024 Aug; 7(8):e2162. PubMed ID: 39118243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of microscopic margin status on survival in adult retroperitoneal soft tissue sarcomas.
    Stahl JM; Corso CD; Park HS; An Y; Rutter CE; Han D; Roberts KB
    Eur J Surg Oncol; 2017 Jan; 43(1):168-174. PubMed ID: 27335080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of postmastectomy radiotherapy in women with pathologic T3N0M0 breast cancer.
    Cassidy RJ; Liu Y; Kahn ST; Jegadeesh NK; Liu X; Subhedar PD; Arciero CA; Gillespie TW; Torres MA
    Cancer; 2017 Aug; 123(15):2829-2839. PubMed ID: 28387923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Controlling Nutritional Status (CONUT) Score is Associated with Poor Long-term Survival in Patients with Low-grade Soft-tissue Sarcomas Treated with Surgical Resection.
    Liang Y; Hou T; Que Y; Zhao B; Xiao W; Zhang X; Zhou Z
    Clin Orthop Relat Res; 2019 Oct; 477(10):2287-2295. PubMed ID: 31107315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.